Competitive progesterone antagonist for demand-oriented female birth control
AssigneeSchering Corporation
InventorsKristof Chwalisz, Klaus Stockemann, Karin Schmidt-Gollwitzer, Walter Klemann
Life of this patent
Estimating the term…
Abstract
This invention describes the novel use of dissociated competitive progesterone antagonists for the production of a pharmaceutical agent for demand-oriented female birth control (pill on demand), which can be used regardless of the point in the menstrual cycle, in a dosage unit that is to be administered on a one-time basis, whose dosage is below the ovulation-inhibiting dosage.
Claims10
A method for demand-oriented female birth control, comprising administering a single dose of a competitive progesterone antagonist at any point in the menstrual cycle, said dosage being below the ovulation-inhibiting dosage and being effective for birth control.
Dependencies are inferred from the claim text.